Mesoblast limited (OTCMKTS:MBLTY) has been assigned a $14.00 target price by equities researchers at Maxim Group in a note issued to investors on Thursday. The brokerage currently has a a “buy” rating on the stock. Maxim Group’s price target would suggest a potential upside of 13.54% from the company’s current price.

Several other research analysts also recently issued reports on MBLTY. Credit Suisse Group AG downgraded Mesoblast limited to a “hold” rating in a research report on Wednesday, June 15th. JPMorgan Chase & Co. restated a “hold” rating on shares of Mesoblast limited in a research report on Wednesday, June 15th.

Shares of Mesoblast limited (OTCMKTS:MBLTY) remained flat at $12.33 on Thursday. Mesoblast limited has a 12-month low of $10.27 and a 12-month high of $19.00. The firm has a 50 day moving average price of $12.26 and a 200-day moving average price of $13.71.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Mesoblast limited Company Profile

Receive News & Ratings for Mesoblast limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast limited and related companies with's FREE daily email newsletter.